Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma

Figure 1 Kaplan-Meier overall survival (A) and progression free survival (B) curves in months from the diagnosis of rectal adenocarcinoma of patients with lower platelet counts (150-300 × 10⁹/L, labeled: nl) vs patients with higher platelet counts (> 300 × 10⁹/L, labeled: thrombo). Log-Rank tests P = 0.47 (A), P = 0.35 (B).

Figure 2 Kaplan-Meier progression-free survival (A) and overall survival (B) curves in months from the diagnosis of rectal adenocarcinoma of patients with a good or complete pathologic response (labeled: Good/compl) vs patients with no response or a minimal or moderate response (labeled: No/min/mod). Log-Rank tests P = 0.01 (A), P = 0.15 (B).